KiNRG, Inc.

What the company does

No publishable business summary is available from the effective-prospectus read.

Use of proceeds

We estimate that the net proceeds from our sale of shares of our common stock in this offering will be approximately $16.10 million, or approximately $18.5 million if the underwriter exercises its over-allotment option in full, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We currently expect to use approximately $11.5 million of the net proceeds as follows: approximately $5,500,000 to fund structural design services for the HTR facility; approximately $3,500,000 to fund engineering services for the HTR facility; approximately $2,500,000 for initial site selection costs; and the remainder, if any, for working capital and general corporate purposes.

Underwriters

Extracted from S-1/A 0001213900-26-109090, filed Oct 13, 2026 and verified against that filing text.

Key risk factors

• Management discretion over use of proceeds

  “Our management might spend a portion or all of the net proceeds from this offering in ways that our stockholders do not desire or that might not yield a favorable return.”

• Concentration of ownership

  “Our directors, executive officers, and their respective affiliates, will beneficially own approximately 44.9 % of our outstanding shares of common stock.”

• Risk of de-listing

  “If after listing we fail to satisfy the continued listing requirements of the NYSE American, the NYSE American may take steps to de-list our common stock.”

• No dividend payments

  “We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future.”

• Anti-takeover provisions

  “Our articles of incorporation and bylaws contain, or will contain upon completion of this offering, certain provisions that may discourage, delay or prevent a change of control that our stockholders may consider favorable.”

• Preferred stock may adversely affect common stock

  “Our Articles of Incorporation authorizes us to issue, without the approval of our stockholders, one or more classes or series of preferred stock having such designations, preferences, limitations, and relative rights, including preferences over our common stock respecting dividends and distributions, as our Board may determine.”

• Substantial sales could cause dilution and price decline

  “If our stockholders sell substantial amounts of our common stock in the public market, the market price of our common stock could fall.”